Carl J. Minniti IIICarl J.Minniti III
Of Counsel, Intellectual Property
Carl Minniti is of counsel in the Litigation Department of Paul Hastings based in the firm’s New York office. His practice primarily focuses on complex patent, trade secret and technology-related litigation, with an emphasis on the life science, medical device and chemical sectors.
Carl has represented biotechnology companies in brand-vs.-brand litigation, contract disputes and cases arising under the Biologics Price Competition & Innovation Act and the Hatch-Waxman Act. His experience includes arguing before federal courts and the Patent Trial and Appeal Board, first-chairing offensive and defensive fact and expert witnesses, developing strategies on infringement, validity and damages issues, drafting briefs and other submissions to the court, and representing clients at trial.
Presently represents Allergan in patent litigation against Revance relating to Allergan’s innovations in its Botox® franchise for botulinum neurotoxin A animal protein-free formulations and manufacturing processes.
Presently represents Allergan in trade secret misappropriation litigation against Revance relating to botulinum neurotoxin A technology.
- Best Academic IP Article at Antitrust Writing Awards — selected by, among others, trade commissioners from the U.S., Hong Kong and EU, in-house counsel and leading academics
"Three Antitrust Cases Drug Companies Should Watch This Year," Law360, Co-Author
January 2018